MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 68 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,373,000 | +1632.1% | 934,155 | +1369.8% | 0.00% | – |
| Q4 2019 | $137,000 | -84.9% | 63,557 | -79.9% | 0.00% | -100.0% |
| Q4 2018 | $906,000 | -49.4% | 315,842 | +76.4% | 0.00% | -50.0% |
| Q3 2018 | $1,790,000 | +61.4% | 179,012 | +14.1% | 0.00% | +100.0% |
| Q2 2018 | $1,109,000 | -49.9% | 156,930 | -72.9% | 0.00% | -66.7% |
| Q1 2018 | $2,212,000 | -70.4% | 579,139 | -36.7% | 0.00% | -70.0% |
| Q4 2017 | $7,471,000 | +46.6% | 915,620 | +5.5% | 0.01% | +25.0% |
| Q3 2017 | $5,095,000 | +4254.7% | 867,927 | +4705.3% | 0.01% | – |
| Q3 2014 | $117,000 | – | 18,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
| Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
| New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
| 683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
| Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
| Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
| THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
| Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
| Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
| GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |